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1. Introduction 
Inflammation and tumors have been demonstrated to have several common characteristics 
in their microenvironments. Extracellular acidosis is frequently associated both with 
inflammation area and tumor growth. Measurements of pH in peripheral tissues during the 
development of inflammation have shown extracellular pH values as low as 5.5–7.0 while 
the pH values of normal tissues are usually maintained at pH 7.4-7.5 mainly via pulmonary 
respiration and kidney perfusion of protons (Edlow & Sheldon, 1971). Similary, the 
extracellular pH in the central regions of tumors decreases below 6.7 in several tumors as a 
consequence of lactate accumulation derived from a lack of sufficient vascularization or an 
increase in tumor specific glycolysis under aerobic conditions combined with impaired 
mitochondrial oxidative phosphorylation (Simmen, 1993; Vaupel, 1989; Warburg, 1956). 
These pH declines affect cellular or tissue functions because their features are determined 
mainly by a variety of enzymatic proteins, and all enzymatic activities have each optimal 
pH. We have previously reported that the low pH conditions alter signal transductions. (1) 
The phosphorylations of several proteins were upregulated at low pH in leukemia cells 
(Fukamachi et al., 2001; Hirara et al., 2008). (2) CTIB, an Ikappa B beta variant, regulates 
cellular survival and gene expression exclusively under acidic environments in Chinese 
Hamster Ovary cells (Lao et al., 2005, 2006). Furthermore, the gene expressions related with 
tumor malignancy were upregulated at low pH in several tumor cell lines (Rofstad et al., 
2006). These different characteristics dependent on extracellular pH provided us with a 
perspective that the inhibitory effect of anti-tumor drugs or molecular targeted inhibitors 
would vary at tumor-specific low pH, and the development of anti-tumor medicines, which 
have medical properties especially in acidic conditions, would lead to curative therapies for 
cancers. 
Malignant mesothelioma is an aggressive tumor developed from the pleura or other 
mesothelioma surface. No efficient method for treatment, including chemotherapy and 
radiotherapy, has yet been established for advanced stage mesothelioma (Zucali & 
Giaccone, 2006). However, the efficacies of anti-tumor agents against not only mesothelioma 
but other tumors under acidic conditions have not yet been investigated exhaustively. Only 
some attributive information has emphasized the possibility of alteration in anti-tumor 
efficacy by extracellular pH and other conditions. The cytotoxicity of mitoxantrone and 
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topotecan was reduced at low extracellular pH in murine EMT6 and in human MGH-U1 
cells (Vukovic & Tannock, 1977). The impaired efficacy of mitoxantrone by acidosis was 
confirmed in M1R rat mammary carcinoma cells (Jähde et al., 1990). MCF-7 human breast 
cancer cells in vitro were more susceptible to doxorubicin toxicity at pH 7.4 compared to pH 
6.8, probably due to its weak base conformation (Raghunand et al., 1999). On the other 
hands, mitomycin C showed higher cytotoxicity at low pH condition against EMT6 tumor 
cells (Rockwell, 1986). The research on pH dependent inhibitory effects has accumulated 
gradually, however the exhaustive investigation of efficacy at low pH using anti-tumor 
agents and molecular targeted inhibitors against mesothelioma is urgent and important for 
combinational therapy of anti-tumor agents or development of new drugs.  
The screening of molecular targeted inhibitors, which inhibit cell growth preferentially at 
low pH conditions, has the potential to produce new therapeutic agents with less adverse 
effect against normal tissues because the development of malignant mesothelioma is 
associated with inflammation derived from asbestos exposure and the insides of 
mesothelioma tissues are also acidificated due to the mechanisms described above (Jähde et 
al., 1992). In order to develop a new therapeutic modality, in this article we discuss the 
effects of tumor specific microenvironments, especially under low pH conditions, on the 
efficacy of classical anti-tumor drugs and molecular targeted inhibitors. 
2. The SCADs inhibitor kits and experimental procedure  
We previously compared the cytotoxic efficacies of 93 molecular targeted inhibitors in 
SCADs inhibitor kit 1 at pH 7.5 and pH 6.7 against HeLa cells (Fukamachi et al., 2010). The 
tumor characteristics, however, differ widely and, moreover, SCADs inhibitor kits 2 and 3 
have a number of other inhibitors, so we examined the cytotoxic efficacies of 272 kinds of 
molecular targeted inhibitors using SCADs inhibitor kits 1, 2 and 3 under different pH 
conditions against mesothelioma cells. 
The inhibitory effects of chemical compounds in the SCADs inhibitor kits at different pH 
conditions were estimated by WST assay, a modified procedure of the MTT assay, as 
described in our previous reports (Fukamachi et al., 2010). Human pleural mesothelioma 
cell line NCI-H2052 was cultured in RPMI-1640 medium. To maintain medium pH for the 
comparison of inhibitory effects under different pH conditions, our group has added Good’s 
buffer to media instead of sodium bicarbonate and found that all tumor cell lines we tested 
can proliferated both at pH 7.5 and 6.7without sodium bicarbonate although the 
proliferation at pH 6.7 was slower than that at pH 7.5. The alteration of medium pH was not 
significant at pH 6.7 whereas the pH of alkaline medium declined to 7.4 after proliferation 
for 5 days (Fukamachi et al., 2001; Lao et al., 2005, 2006). 
3. The effect of extracellular pH on classical anti-tumor agents against 
mesothelioma 
SCADs inhibitor kits include 17 anti-tumor medicines those have already been prescribed 
for treatment of cancers. As shown in Table 1, none of the classical anti-tumor agents 
achieved better results against mesothelioma under acidic conditions. Cisplatin, 
mitomycin C, daunorubicin, aclarubicin, vinblastine sulfate, doxorubicin and cytochalasin 
D showed less cytotoxicity under acidic conditions. No pH dependency was seen with 
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bleomycin sulfate, paclitaxel, actinomycin D, camptothecin or etoposide (Table 1, Fig.1). 
The remaining 6 medicines did not reduce cellular survival independently from medium 
pH at 2 microM.  
higher cytotoxicity at low pH 
lower cytotoxicity at low pH Cisplatin,  Mitomycin C,   Daunorubicin/HCl, Doxorubicin/HCl
Vinblastine sulfate, Aclarubicin,   Cytochalasin D
no different cytotoxicity 
between pH 6.7 and 7.5
Bleomycin sulfate,   Paclitaxel,  Actinomycin D, Camptothecin
Etoposide
no cytotoxicity 
under 2 micro M
5-FU, Bestatin,  Methotrexate, Flutamide, Tamoxifen/citrate 
Cytotoxicity at different pH
 
Table 1. Cytotoxicity of classical anti-tumor drug at different pH conditions. 
3.1 Cisplatin 
The cytotoxicity of cisplatin has been reported previously to show high sensitivity at low pH 
in EMT mouse tumor or leukemia (Laurencot & Kennedy, 1995). However, the cytotoxicity 
against NCI-H2052 mesothelioma was impaired at pH 6.7 as shown in Table.1 and Fig.1. We 
suppose that this difference was derived from the alteration of intracellular pH value 
dependent on extracellular pH value and the composition of nutrients. In previous 
experiments, the medium pH values were set at pH 6.0 as acidic conditions in contrast to the 
pH value 6.7 in our reports. We confirmed that the intracellular pH values are maintained at 
pH above 7.1 in cells incubated in the medium with 10% FBS at pH 6.7 (data not shown). In 
addition to our experiments, the maintenance of intracellular pH values in weak acidic 
conditions was again confirmed in other tumor cell lines (Gerweck & Seethaaraman, 1996; 
Owen et al., 1997). Extracellular pH lower than 6.5, however, markedly reduced intracellular 
pH values (Rockwells, 1986). This large reduction of intracellular pH values has been 
associated with apoptosis being independent of the presence of anti-tumor agents, so the 
enhanced effect of cisplatin under acidic conditions below pH 6.0 might be derived from 
another mechanism. Although the pH sensitive, anti-tumor bis (aminoalcohol) 
dichloroplatinum(II) has been developed, but its low pH dependent cytotoxicity appeared 
pH only below pH 6.0 (Zorbas-Seifriends et al., 2006). The extracellular pH values in 
mesothelioma, are usually over 6.7 (Jahde et al., 1992), so we presume that the cytotoxic 
potential of cisplatin is reduced around at pH 6.7 in mesothelioma.  
The mechanism of resistance against cisplatin under low pH conditions is unknown. 
Cisplatin-resistance has been related with the activity of several proteins such as BRCA1, 
which plays multiple role in DNA repair, or p21WAF1/CIP1 proteins (Alli et al., 2011; Wei 
et al., 2010). Although the activity of these proteins at pH 6.7 has not been investigated, 
acidosis affects several protein activity (Lao et al., 2006; Rofstad et al., 2006). So the alteration 
of these proteins’ activity may contribute to the Cisplatin-resistance at low pH. 
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Fig. 1. pH-dependent cytotoxicity of classical anti-tumor drug. 
3.2 Mitomycin C 
Mitomycin C was reported to be potently its cytotoxic at low pH conditions against EMT6 
tumor cells and this was associated with the upregulated binding of mitomycin C to DNA 
at low pH conditions (Rockwells, 1986). This result is different from our results, as shown 
in Table.1 and Fig.1. The medium pH values were at pH 5.7 in previous experiments, so 
probably the cytotoxicity of mitomycin C would be reduced at around pH 6.7. Resistance 
to mitomycin C by several cancers has been reported and related with glutathion  
S-transferase activity (Ruiz-Gomez et al., 2000). So the quantification of the expression or 
activity of glutathion S-transferase under acidic conditions may be important. Although 
the treatment against mesothelioma using mitomycin C has been investigated, its efficacy 
was less than those of cisplatin (Fennell et al., 2007) or oxalipalatin (Routh et al., 2011).  
In contrast, Co-treatment with mitomycin C, vinblastin and cisplatin achieved  
the improvement of symptoms including cough, dyspnoea and pains (Andreopoulou et 
al., 2004). So treatment with mitomycin C might be limited to improving the quality of 
life. 
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3.3 Doxorubicin and daunorubicin  
The therapeutic effects of doxorubicin and daunorubicin against mesothelioma have been 
linked with the tumor-resistance mechanism of mesothelioma. Single treatment with 
doxorubicin and daunorubicin showed no significant anti-tumor activity (Harvey et al.,1984; 
Steele et al., 2001). Although this combination with cisplatin achieved some slight 
improvement, a high dose of doxorubicin was needed and this showed a toxic rather than 
curative effect (Stewart et al., 1994). These impaired efficacies of doxorubicin in 
mesothelioma have been thought to be due to upregulation of p-glycoprotein mediated 
drug efflux (Isobe et al., 1994) or multi drug associated protein (Kato et al., 1998). The 
expression of p-glycoprotein was up-regulated at low pH conditions in EMT6 cells and 
prostate cancer cells (Thews et al., 2006 ). This upregulation of p-glycoprotein is partially 
dependent on HIF-1 (Riganti et al., 2008) and extracellular low pH has been reported to 
induce HIF-1 (Mekhall et al., 2004). So, this mechanism might contribute to the pH-
dependent loss of cytotoxicity as shown in Fig.1, in addition to the possibility derived from 
its weakly basic conformation (Raghunand et al., 1999). Drug resistance is also influenced by 
the activity of ROS scavengers. Most mesotheliomas express relatively large amount of 
manganese superoxide dismutase, catalase and cell surface NADH oxidase, and the 
cytotoxicitic function of ROS derived from doxorubicin were impaired in mesothelioma 
(Hedges et al., 2003; Kahlos et al., 1998).  
3.4 Vinblastine sulfate, aclarubicin and cytochalasin D 
These three agents has not been investigated at low pH conditions yet. So our experiment 
shown in Fig.1 was the first to show less cytotoxicity under acidic conditions. The reduced 
cytotoxicity of these three drugs, however, might be explained by the pH-dependent 
upregulation of p-glycoprotein as well as doxorubicin because vinblastine is also a p-
glycoprotein substance (Gertner et al., 1998). Recent data indicated that the use of 
vinblastine should be limited to the improvement of symptoms as described above for 
mitomycin C (Andreopuoulou et al., 2004). It has been reported that the anti-tumor activity 
of aclarubicin is related to the production of ROS (Rogalska et al., 2008). So the 
mesothelioma cell, which expresses elevated amounts of ROS scavengers, may be resistant 
to aclarubicin. 
The effects of cytochalasin D are derived from the breaking of actin filaments (Schiliwa, 1982). 
Human actin-depolymerizing factor and cofilin have been reported to be pH-sensitive (Pope et 
al., 2004). So this mechanism is likely to be associated with our results shown in Fig.1. 
3.5 The pH dependency of other anti-tumor agents 
Bleomycin was reported to show pH dependency in restricted conditions. The combination 
of high temperature and low pH enhanced the efficacy of bleomycin and 1,3-bis(2-
chloroethyl)-1-nitrosourea but not methotrexate against Chinese hamster ovary, while there 
was no effect of pH at normal tissue temperature (Hahn & Shiu, 1983). The efficiency of 
bleomycin at low pH and high temperature has not been estimated against mesothelioma 
yet in vitro and vivo. Hyperthermia with bleomycin, however, may be worthwhile to 
examine against mesothelioma. 
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Although 5-Fluorouracil (5-FU) did not show cytotoxicity under both pH conditions as 
shown in Fig.1, high dose 5-FU previously showed the potential for pH dependent 
mesothelioma suppression (Nissen & Tanneberg, 1981). 5-FU inhibited the 3H-uridine 
incorporation preferentially at pH 7.4 compared to that at pH 6.8 at concentrations above 
100 microM, so the comparison at each pH with higher doses of 5-FU is needed. 
4. The effect of extracellular pH on molecular targeted inhibitors 
As shown in Table 2, only four molecular targeted inhibitors, lovastatin, manumycin A, FTI-
276 and cantharidin, showed higher cytotoxicity at low pH conditions in our exhaustively 
investigation against mesothelioma at different pH conditions using SCADs inhibitor kit. 
The inhibitory effect of aphidicolin, bisindolymaleimide I, N1,N12-diethylspermine, PKR 
inhibitor were impaired at low pH (Table 2, Fig.2). 
higher cytotoxicity at low pH 
lower cytotoxicity at low pH
no different cytotoxicity 
between pH 6.7 and 7.5
Manumycin A, FTI-276, Cantharidin,   Lovastatin
Aphidicolin, Bisindolymaleimide I/HCl, N1,N12-Diethylspermine
Scriptaid, Trichostatin A, Cycloheximide, Radicicol, 17-AAG, Cucurbitacin
PD 98059, MG-132, Lactacystin, Oligomycin, Bafilomycin A1, SB 225002
Monensin, Ouabain, Sanguinarine, Valinomycin, Nigericin, A23187
Ionomycin, Thapsigargin, Rotenone, Leptomycin B*, LY 83583, Chetomin 
-Amanitin, MST-312, Akt Inhibitor IV, ATM kinase inhibitor
Cdk2/9 inhibitor,  AGL 2263,  IKK-2 inhibitor VI, JAK Inhibitor I, PP2
SU11652,  PDGF receptor tyrosine kinase inhibitor IV, LY-294002 
Wortmannin, Go7874,  KT5823, ZM 336372, SU1498
VEGFR receptor tyrosine kinase inhibitor III
Cytotoxicity at different pH
PKR inhibitor
VEGF recptor 2 kinase inhibitor
 
Table 2. Cytotoxicity of molecular targeted inhibitor at different pH conditions. 
4.1 Statin  
4.1.1 The therapeutic capacity of statins against cancers 
The pH-dependent cytotoxicity of lovastatin was observed previously in HeLa cells, 
mesothelioma cell line H2452 cells, pancreatic tumor cell line, BxPC-3 and Panc-1. Moreover, 
simvastatin, another lipophilic statin, inhibited cellular survival of HeLa cells as well as 
lovastatin (Fukamachi et al., 2010). These results indicated that pH-dependent cytotoxicity 
of lovastatin is common to several tumors and that other statins have similar properties. 
Statins (3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) block the de novo 
synthesis of cholesterol, resulting in lower plasma cholesterol levels. Although myopathy or 
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its more severe form rhabdomyolysis is a significant adverse effect of statin treatment, the 
incidence is typically less than 0.1% (Ballantyne et al., 2003). Other adverse effects including 
hyperplasia of the liver, squamous epithelial hyperplasia of cataracts and vascular lesions in 
the central nervous system have lower incidences or need extreme inhibition of the enzyme 
with high doses of statins (Gerson et al., 1989). Due to its active effect against cholesterol 
synthesis and relatively safe features, lovastatin and other statins have been prescribed for 
treatment of hypercholesterolaemia since the late 1980s (Tobert, 2003). Furthermore, statins 
might have potential for other coronary artery diseases. In patients without established 
cardiovascular disease but with cardiovascular risk factors, statin use was associated with 
significantly improved survival and large reductions in the risk of major cardiovascular 
events (Bruqts et al., 2009). 
In addition to its great curative effect for vascular disease, the relationship of statin with 
cancer treatments has been discussed, including mesothelioma. Lovastatin inhibited the 
growth of T cell leukemia (Newman et al., 1994), pancreatic tumor (Muller et al., 1998), 
glioma (Jones et al., 1994), lung cancer (Maksimova et al., 2008) and prostate cancer (Hoque 
et al., 2008). Other statins as well as lovastatin showed cytotoxicity against tumor cell lines. 
Simvastatin against HT29 human colon cancer cells (Cho et al., 2008), glioma (Wu et al., 
2009), pravastatin against hepatoma (Kawata et al., 1992) have been reported. Moreover, 
several statins reduced the migration of human pancreatic tumors and mouse melanoma 
(Kusama et al., 2002). In addition to the cytotoxicity and suppression of invasion against 
tumor cell lines, statins’ curative effect against several cancers was confirmed in patients. 
Conventional chemotherapy using simvastatin with irinotecan, 5-FU and leucovorin 
(FOLFIRI) was a feasible regimen with promising anti-tumor activity against metastatic 
colorectal cancers (Lee et al., 2009). Fluvastatin reduces proliferation and increases apoptosis 
in women with high grade breast cancer (Garwood et al., 2010). These results indicated that 
statins inhibit tumor proliferation and have the potential to be applied for cancer treatments.  
4.1.2 The mechanism of statins cytotoxicity; cholesterol and protein prenylation  
The mechanism underlying statins’ pH-dependent cytotoxicity is unclear. Statins inhibit 
HMG-CoA reductase that converts HMG-CoA to mevalonate, resulting in the reduction of 
farnesyl pyrophosphate, a substance of cholesterol. The important feature of cholesterol is 
that cholesterol is critical substance in plasma and vesicle membranes, so the inhibition of 
cholesterol synthesis by statins reduces mitochondrial membrane potential and induces the 
release of pro-apoptotic factors including cytochrome c, resulting in the apoptosis or the 
increase of doxorubicin sensitivity in hepatocellular carcinoma (Montero et al., 2008). The 
amount of cholesterol also contributed to the tumor cell migration (Sekine et al., 2010). These 
contribution of cholesterol to tumor movement were impaired by the reduction of 
cholesterol by statins (Murai et al., 2011). 
Another cascade downstream of the mevalonate pathway might be important to influence 
cellular function or tumor survival. Farnesyl pyrophosphate is converted into 
geranylgeranyl pyrophosphate and both phosphates are substances of protein prenylation. 
Proteins acquire lipophilicity with prenylation by farnesyl transferase or geranylgeranyl 
transeferase and bind to membrane or hydrophobic grooves on the surface of soluble 
protein factors (Gelb et al., 2006). In association with tumors, the prenylation of low 
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molecular mass G protein has been examined, because their membrane association is 
induced by prenylation (Finegold et al., 1990). Lovastatin inhibits the prenylation of G 
proteins and alters their localization (Girgelt et al., 1994; Muller et al., 1998). Simvastatin 
interfered with angiogenesis via inhibition of the geranylgeranylation and membrane 
localization of RhoA (Park et al., 2002). RhoA activity and JNK, downstream of RhoA, were 
also inhibited by atorvastatin, resulting in the suppression of osteosacroma invasion 
(Fromigue et al., 2008). In addition, Rab protein, which was recently reported to be involved 
in protein transport across the secretory, was geranylgeranylated by Rab geranylgeranyl 
transferase, and mediated cancer invasion (Leung et al., 2006).  
4.1.3 The mechanism of statins cytotoxicity; downstream of G protein 
In the downstream of these low molecular mass G protein prenylations, statins induced an 
mTOR-dependent Ser166 phosphorylation of Mdm2, and this effect may attenuate the 
duration and intensity of the p53 response to DNA damage in hepatocytes (Paajarvi et al., 
2005). Atorvastatins induce autophagy and autophagy-associated cell death in PC3 cells, 
likely through inhibition of geranylgeranylation (Parikh et al., 2010). GGTI-286, an inhibitor 
of geranylgeranyl transeferase, induced G0/G1 arrest and p21 resulting in tumor 
suppression (Vogt et al., 1997). These effects derived from p21 were related with the 
inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2(Lin 
et al., 2008). Lovastatin induced U87 glioblastoma cell death in correlation with significantly 
increased levels of the BH3-only protein and the activation of MAPK. All of these alterations 
were prevented by geranylgeranyl pyrophosphate (Jiang et al., 2004). Statins have the 
potential to regulate gene expression related with cancer progression. MMP-9 reduction by 
lovastatin resulted in the suppression of invasion (Wang et al., 2000). Pitavastatin at low 
dose inhibits NF-kappaB activation and decreases IL-6 production induced by TNF-alpha 
(Wang & Kitajima, 2007). Atorvastatin inhibits inflammatory angiogenesis in mice through 
down-regulation of VEGF, TNF-alpha, and TGF-beta1 (Araujo et al., 2010). These reports 
suggest that several cancers are sensitive to statins and the inhibitors of protein prenylation. 
4.1.4 The effect of statins against mesothelioma under acidic conditions 
In contrast to statins’ inhibitory effect against several cancers, little has been reported about 
the treatment of mesothelioma with statins or prenylation inhibitors. A few previous reports 
and our results, however, stress the possibility of mesothelioma treatment by statins. 
Lovastatin reduced malignant mesothelioma viability with altering the membrane 
association of Ras, and this cytotoxic effect was impaired by addition of mevalonate (Rubins 
et al., 1998). It is still unclear whether the cytotoxicity was dependent on the reduction of 
cholesterol or on the prenylation of proteins. In regard to the doxorubicin sensitivity of 
mesothelioma up-regulated by statins, the inhibition of protein prenylation was thought to 
potentiate the cytotoxicity of doxorubicin (Riganti et al., 2006). Both mevastatin and 
simvastatin increased the doxorubicin sensitivity via the increase of NO, and this effect was 
mimicked by GGTI-286 and Y-27632, an inhibitor of ROCK which is a downstream protein 
of Rho GTPase. Although, there has been no discussion about the contribution of the 
decreased cholesterol, the decline of cholesterol level would reduce the mitochondrial 
membrane potential, resulting in the release of pro-apoptotic protein. So both mechanisms 
are thought to contribute to the up-regulation of doxorubicin sensitivity. 
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Our resent results indicated that mesothelioma cells can proliferate under acidic conditions, 
and the pH-dependent cytotoxicity was due to the pH-dependent activity of prenylated 
proteins or the pH-dependent alteration of protein prenylation because manumycin A, an 
inhibitor of farnesyl and geranylgeranyl transferase, showed pH-dependent cytotoxicity as 
well as statins while no pH-dependent cytotoxicity appeared with YM-53601, an inhibitor of 
squalene synthase (Fukamachi et al., 2010). This importance of protein prenylation was 
reinforced by our result that three out of the only four inhibitors including FTI-276, an 
inhibitor of farnesyl transferase, are related with protein prenylation as shown in Table 2. It 
is not clear which protein’s prenylation or activity is important in mesothelioma cells under 
acidic conditions. The signal transductions under acidic environments are different from 
those at normal tissue pH. The phosphorylation of p38 was increased at low pH (Hirata et 
al., 2008). The activity of the Erk/Ap-1 pathway is also activated at low pH in melanoma 
cells (Kato et al., 2005). These results indicate that the upstream proteins of MAPK are likely 
to be important at low pH. In fact, the activity of ERK in cardiac myocytes at low pH was 
related with Ras activation (Haworth et al., 2006). The morphological changes under acidic 
conditions were associated with Rho kinase (Hyvelin et al., 2004). Rab11b and its mediator 
Rip11 regulate V-ATPase traffic elevated at low pH in duct cells (Oehike et al., 2011). These 
results suggested that low molecular mass G protein might be important in tumor 
proliferation under acidic conditions. It remains unclear yet why statins inhibit cellular 
proliferation preferentially in tumor growth. Recently, a novel approach to identify 
geranylgeranylated protein was developed using azide binding geranylgeraniol which 
converted to geranylgeranyl pyrophosphate in cytosol (Chan et al., 2009). So the proteins, 
which play a critical role for mesothelioma proliferation at low pH, will be identified soon. 
4.2 Cantharidin 
4.2.1 The mechanism of cantharidin to suppress tumor growth 
Cantharidin, a natural compound isolated from beetles, has the inhibitory activity of protein 
phosphatase (PP2A or PP1). Cantharidin was first found to be effective against various 
warts (Cusack et al., 2008). Cantharidine has also been traditionally used as an anti-cancer 
agent in China (Pang et al., 2007). The mechanism against cancer via the inhibition of protein 
phosphatase is poorly understood except for a few reports regarding to apoptosis and signal 
pathways. Cantharidin caused G2/M arrest through inhibition of CDK1 activity (Huang et 
al., 2011) and apoptosis via mitochondrial pathways including Bax, Bcl-2, Bcl-xl resulting in 
caspase activation (Kok et al., 2005). Cantharidin was recently shown to have passive 
cytotoxicity against tumor cells via the JAK/STAT pathway (Sagawa et al., 2008) and the 
involvement of NF-kB pathways in cantharidin-induced apoptosis was also reported (Li et 
al., 2011). 
4.2.2 The problem with cantharidin and derivatives of cantharidin  
Although these features of cantharidin are important for anti-tumor activity, the clinical 
application of cantharidin is limited due to its severe side-effects and highly toxic nature. 
The protein phosphatase-inhibitory toxins have been shown to induce hyper- 
phosphorylation of cytoskeletal proteins like keratin in isolated rat hepatocytes, and to cause 
disruption of the intracellular network of keratin intermediate filaments (Blankson et al., 
1995). The toxins also inhibit hepatocellular processes like autophagy, endocytosis, and 
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protein synthesis and elicit apoptotic cell death when administered to hepatocytes in culture 
(Blankson et al., 2000).  
Therefore, the development of more selective and effective analogs of cantharidin with less 
toxicity has become a challenge for cancer treatment. LB1.2, a synthesized cantharidin 
derivative, showed significant enhancement of cancer chemotherapy on glioblastoma and 
neuroblastoma cancer cells with no acute or chronic toxicity. This tumor-suppressive effect 
was derived from the quiescent cells cycle and caused by blocking other replication 
checkpoints triggered by DNA damage through the significant inhibition effect of PP2A 
(Rajski & Williams., 1998). Norcantharidin (NCTD) is another demethylated derivative of 
cantharidin possessing anti-cancer activity less toxic to normal cells, and has been used to 
gastric cancer (McCluskey., 2002). NCTD inhibited the activity of PP2A, and was able to 
promote the cell cycle from G1 to S phase with subsequent G2/M arrest (Yu et al., 2006). In 
addition to this phosphatase inhibitory effect, recent studies have demonstrated that 
cantharidin and NCTD can cause DNA damage, which may be the main contributory factor 
in the cytotoxicity of NCTD and cantharidin (Efferth et al., 2005). NCTD-induced caspase-
dependent apoptosis was accompanied by an increase in ROS production, loss of 
mitochondrial membrane potential with release of cytochrome c from the mitochondria to 
the cytosol, and down-regulation of anti-apoptotic protein Bcl-2 (Chang et al., 2010).  
4.2.3 The therapeutic capacity of cantharidin against mesothelioma 
Combinational therapy with these new cantharidin derivatives may be used for treatment of 
mesothelioma. In combinational treatment with doxorubicin and LB1, the effectiveness of 
doxorubicin was greatly enhanced by the LB1 in the xenograft growth inhibition and lung 
metastases prevention of an aggressive sarcoma derived from transformed mesenchymal 
stem cells in syngeneic rats with little side toxicity (Zhang et al., 2010). Meanwhile, there 
have been several reports to show that cantharidin and its derivatives are relatively 
ineffective as an anti-cancer agent (Jiang et al., 1983). The contradiction may be related to 
cantharidin being less effective at alkaline pH but more active at acidic pH (Fukamachi et 
al., 2010) 
It remains unclear why cantharidin inhibits more strongly at acidic pH and which pathways 
are inhibited by cantharidin under acidic environments. The protein phosphatase, which has 
been related with mesothelioma proliferation, is mainly PTEN (phosphatase and tensin 
homologue deleted from chromosome 10). The activity of PTEN was suppressed in 
mesothelioma (Opitz et al., 2008), and the elevated PI3K/Akt pathway, which is the target 
pathway of PTEN, was repeatedly confirmed and related with mesothelioma proliferation 
(Altomare et al., 2005). So the inhibition of PTEN by cantharidin is not likely to lead to 
mesothelioma death. In other cell tumors, cantharidin induced G2/M arrest through 
inhibition of CDK1 (Huang et al., 2011), and induced NF-kappaB activity via constitutive 
phosphorylation of IKK. So the sensitivity of these proteins, especially NF-kappaB, to low 
pH may be important because the translocation of NF-kappaB was altered dependent on 
extracellular pH in T cells (unpublished data). Taken together, the pharmacologic inhibition 
of PP2A with less-toxic cantharidin derivatives may be a useful strategy against 
mesothelioma as a single treatment or combined with other anti-tumor agents including 
doxorubicin. 
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4.3 The impaired effect of molecular targeted inhibitors 
4.3.1 Aphidicolin 
Aphidicolin is a specific inhibitor of DNA polymerase alpha and delta, resulting in DNA 
double-strand breaks leading to the activation of Ataxia-Telangiectasia Mutated: ATM (Ge 
& Blow, 2010), the inhibition of DNA replication and cell cycle arrest in G1/S phase (Dhillon 
et al., 2003). The impaired activity of aphidicolin at pH 6.7 shown in Table 2 and our 
previous result (Fukamachi et al., 2010) suggested that mesothelioma cells might have an 
acquired resistance to DNA double-strand breaks. Recently, an aphidicolin-resistant 
Chinese hamster V79 cell mutant had aphidicolin-resistant DNA polymerase that had an 
increased affinity for dNTP (Syljuasen et al., 2007). Furthermore, the checkpoint adaptation 
was observed in aphidicolin-treated Xenopus, and this system was expected to function in 
human cells (Herbst et al., 2003). The mechanism by which mesothelioma proliferates at pH 
6.7 with aphidiconis is unclear yet. The most important point is that the ATM signal above 
has been thought to contribute to the exclusion of DNA mutated cells leading to 
tumorgenesis or tumor malignancy. Our result (Fig.2) may suggest that the extracellular 
acidosis influences tumor malignancy via impaired ATM signals. 
4.3.2 Bisindolmaleimide 
Bisindolmaleimide is a specific inhibitor of PKC (Toullec et al., 1991). PKC is a ubiquitous 
phospholipid-dependent serine/threonine kinase involved in major signaling events that 
regulate cellular growth, migration, apoptosis, and a wide variety of biological responses 
to stimuli (Sukumaran & Prasadarao, 2002). Several studies have indicated that the 
inhibition of PKC represses tumor proliferation although it depend on the PKC class (Hu 
et al., 2011; Toton et al., 2011). PKCbeta1 was expressed in the majority of MPM and the 
treatment of MPM cell lines with PKC inhibitor showed synergy when combined with 
cisplatin in vitro (Faoro et al., 2008). Moreover the inhibition of protein kinase C prevents 
asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells (Fung et 
al., 1997). Despite these results relating tumor progression with PKC, our results showed 
less sensitivity to Bisindolmaleimide (Table 2 & Fig.2). The suppressive acitivity of PKC at 
low pH was demonstrated in prostate carcinoma (Thews et al., 2006). So the impaired 
activity of Bisindolmaleimide may be due to the decline of PKC activity under acidic 
conditions. 
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Fig. 2. pH dependency of molecular targeted inhibitors 
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4.3.3 PKR inhibitor  
PKR, double-stranded RNA dependent protein kinase R, is activated by heme deficiency, 
the absence of amino acids, folded proteins accumulated in the ER, and dsRNA. The 
activated PKR phosphorylates eIF2α, and the phosphorylated eIF2α acts as a dominant 
inhibitor of the guanine exchange factor eIF2B, which prevents the recycling of eIF2 between 
succeeding rounds of protein synthesis and eventually leads to a global obstruction of 
mRNA translation initiation. This allows cells to adapt to stressful conditions by 
economizing on energy expended by protein synthesis (Wek et al., 2006). The adaptation 
process of eIF2α phoshorylation involves the selective translation of transcription factors 
such as activating transcription factor 4 (ATF4) (Vattem & Wek, 2004) and ATF5 (Zhou et al., 
2008), which induce the expression of genes that facilitate adaptation. In cases of prolonged 
stress, the induction of eIF2α phosphorylation leads to cell death through the induction of 
apoptotic pathways (Wek et al., 2006). The results in Fig. 2 may suggest that the activity of 
PKR is less important in the proliferation of mesothelioma under acidic condition. Acidic 
conditions, in fact, enhanced the phosphorylation of eIF2, but this was confirmed at pH 
lower than 5.5 and not over 6.2 in a partially PKR-independent manner (Vantelon et al., 
2007). So the phosphorylation of eIF2 without PKR at pH 6.7 might not cause this PKR 
independency at pH 6.7. Recently, there has been strong evidence to suggest that 
mammalian eIF2α kinases including PKR can also mediate activate glycogen synthase 
kinase 3 to promote the proteasomal degradation of p53 independently of eIF2α 
phosphorylation (Baltzis et al., 2007). So another mechanism may be critical in this reduced 
inhibitory effect at low pH. 
4.3.4 The impaired effect of N1,N12-Diethylspermine 
N1,N12-Diethylspermine lost its cytotoxic activity as shown in Table 2 and Fig. 2. N1, N12 -
Diethylspermine (BESpm) caused a specific induction of spermidine/spermine N'-
acetyltransferase (SSAT) activity, a cytosolic enzyme is induced in response to a variety of 
toxic agents, hormones and polyamine derivative (Casero et al., 1990). Polyamines are 
aliphatic cations present in all cells. SSAT is a rate-limiting step in polyamine catabolism, 
which catalyzes the transfer of the acetyl group from acetyl-CoA to the spermidine or 
spermine and has a predominant role in the regulation of intracellular polyamine 
concentrations in mammalian cells (Vujcic et al., 2000). Decreases in polyamines have been 
shown to promote decreased growth or apoptosis (Khan et al., 1992), depending on the cell 
type and the particular stimulus, suggesting a complex interaction between polyamines, cell 
growth, and cell death. Therefore, although polyamines are required for cell growth and 
differentiation, SSAT is thought to prevent overaccumulation of the higher polyamines from 
becoming toxic to the cell and may play a role in reducing the growth rate by decreasing 
intracellular polyamines. It has been shown that the regulation of SSAT by the natural 
polyamines and the anti-tumor polyamine analogues is through the polyamine response 
element (Wang et al., 1998). Furthermore, the superinduction of SSAT by polyamine 
analogues has been implicated in the cell type-specific cytotoxic response of several 
important human tumors including human lung cancer (Casero et al., 1990, 1992; Chang et 
al., 1992; Kim et al., 2005). Consistent with these previous reports, BESpm reduced cellular 
survival at pH 7.5 against mesothelioma as shown Fig. 2, probably via the inhibition of 
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SSAT by BESpm, leading to the desruption of polyamine regulation while no inhibitory 
effect was observed at pH 6.7. This result suggests that proliferation of mesothelioma cell 
line may be independent of the regulation of polyamine. 
5. Novel anti-tumor therapy being dependent on pH 
5.1 The effect of Alkylating drug 
Some alkylating anti-tumor drugs including chlorambucil, carboquone and 
cyclophosphamide were reported to have higher cytotoxocity at low pH, probably because 
of their weak acid conformation or the decrease of drug resistance (Mikkelsen et al., 1985). It 
is difficult, however, to use them due to their causing the development of other tumors in 
common with alkyl agents (Rai et al., 2000). 
5.2 Lowering the intracellular pH using nigericin 
Low intracellular pH has been associated with enhanced cytotoxicity of anti-tumor drugs, so 
drugs to reduce intracellular pH have been investigated. The intracellular pH is higher than 
the extracellular pH, as mentioned above, so nigericin, an ionophore that acidifies the 
cytoplasm by exchanging cations with protons in cells placed in medium at low pH, was co-
incubated with anti-tumor agents. Amiloride and 4,4'-diisothiocyanostilbene 2,2-disulfonic 
acid, inhibitors of the Na/H and HCO3/Cl exchangers, respectively, decreased intracellular 
pH in the presence of nigericin at low extracellular pH against Chinese hamster ovary and 
human bladder cancer MGH-U1 cells (Rotin et al., 1987).  
5.3 The pH-dependent cytotoxicity of N-dodecylimidazole 
N-dodecylimidazole is a compound, which acquires detergent properties under acidic 
conditions, and is thought to be useful for selectively killing cells under intratumor low pH 
environments. N-dodecylimidazole displayed pH-dependent cytotoxicity against EMT-6 
and MGH-U1 cells. The cytotoxicity was enhanced 100-fold at pH 6.0 compared with pH 7.0 
(Boyer et al., 1993). However, these liposomal formulations need to be optimized to achieve 
higher concentrations of pH-sensitive detergents within the endosome to facilitate efficient 
cytosolic release of liposome-entrapped contents (Chen et al., 2003). Various kinds of pH 
sensitive detergents have recently been developed to carry the anti-tumor drugs to the 
tumor nest, burst, and effuse the contents, dependent on the tumor pH. An acid-cleavable 
PEG lipid, 1'-(4'-cholesteryloxy-3'-butenyl)-omega-methoxy-polyethylene glycolate (CVEP), 
has been developed that produces stable liposomes when dispersed as a minor component 
(0.5-5 mol %) in 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). Cleavage of CVEP 
at mildly acidic pH results in dePEGylation of the latently fusogenic DOPE liposomes, 
thereby triggering the onset of content release (Boomer et al., 2009). Physical and chemical 
instabilities have limited the use of these drug carriers as pharmaceutical products. 
Recently, however, the preparation of freeze-dried pharmaceuticals has proven to be a 
successful strategy implemented to improve the stability of these formulations. Long-
circulating and pH-sensitive liposomes containing Cisplatin are now being applied in vivo 
experiments (Giuberti et al., 2010).  
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5.4 The pH dependent cytotoxicity of tirapazamine 
Low pH can substantially potentiate the cytotoxic effect of the bioreductive drug 
tirapazamine in HT-29 human tumor cells (Skarsgard et al., 1993). Tirapazamine is the lead 
member of a class of bioreductive drugs and requires metabolic activation to give a cytotoxic 
free radical species via a variety of cellular reductases, including NADPH cytochrome c 
reductase (Chinje et al., 2003). Combination therapy with tirapazamine and cisplatin has 
shown increased treatment efficacy compared with cisplatin alone in malignant melanoma 
and non-small-cell lung cancer, and also may be of benefit when combined with both 
radiotherapy and cisplatin in head and neck cancer (Williams et al., 2001). 
6. Conclusion  
As discussed in this review, there are no classical anti-tumor drugs which show high 
cytotoxicity against mesothelioma at pH 6.7. So it might be much important to prescribe 
both drugs whose cytotoxicity is enhanced at low pH and drugs which induce cell death at 
normal tissue pH for mesothelioma treatment. Although classical anti-tumor medicines 
have potent tumor suppressive effects, they also have severe toxicities for normal tissues. So 
the therapeutic regimes with lesser amounts of classical anti-tumor agents are urgently 
required. To this end, drugs which show higher cytotoxicity at low pH, including statins 
and cantharidins would be conventional candidates for co-treatment of mesothelioma. In 
fact, the combination treatment of solid tumors with statins enhanced anti-tumor drugs in 
vivo (Agarwal et al., 1999; Gao et al., 2010; O’Brien et al. 2003; Zhao et al., 2010). So the 
development of new compounds with anti-tumor activity preferentially at low pH would be 
useful for chemotherapy of mesothelioma. 
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